Ensysce Biosciences Discusses TAAP and MPAR® Applications and OncoZenge Partnership with The Stock Day Podcast

The Stock Day Podcast welcomed Ensysce Biosciences (Nasdaq:ENSC)(“the Company”), a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. CEO of the Company, Dr. Lynn Kirkpatrick, joined Stock Day host Matthew Dunehoo.